Life Saving Drugs Program – Paroxysmal nocturnal haemoglobinuria – Medicines review protocol

This final protocol describes the methodology reviewers will follow to assess use of Life Saving Drugs Program medicines for paroxysmal nocturnal haemoglobinuria.

Downloads

Life Saving Drugs Program – Paroxysmal nocturnal haemoglobinuria – Medicines review protocol

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Publication type:
Procedure
Audience:
General public
Language:
English
Description:

The reviewers will use data sources specified in this document and results of stakeholder consultation to describe:

  • prevalence of paroxysmal nocturnal haemoglobinuria (PNH) in Australia
  • management of PNH in comparison to Life Saving Drugs Program (LSDP) guidelines
  • clinical and comparative effectiveness and safety of medicines
  • relevant patient-based outcomes
  • value for money of LSDP treatment for PNH
  • use of the LSDP PNH medicines
  • developing technologies that may impact future access.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.